These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

925 related articles for article (PubMed ID: 21923281)

  • 21. Knowledge and Acceptability of Long-Acting Reversible Contraception Among Adolescent Women Receiving School-Based Primary Care Services.
    Hoopes AJ; Ahrens KR; Gilmore K; Cady J; Haaland WL; Amies Oelschlager AM; Prager S
    J Prim Care Community Health; 2016 Jul; 7(3):165-70. PubMed ID: 27067583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of behavioral methods of contraception in women seeking abortion.
    Sparrow MJ
    N Z Med J; 1997 Oct; 110(1054):393-5. PubMed ID: 9397083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A qualitative analysis of long-acting reversible contraception.
    Sundstrom B; Baker-Whitcomb A; DeMaria AL
    Matern Child Health J; 2015 Jul; 19(7):1507-14. PubMed ID: 25424456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-abortion initiation of long-acting reversible contraception in New Zealand.
    Rose SB; Garrett SM
    J Fam Plann Reprod Health Care; 2015 Jul; 41(3):197-204. PubMed ID: 25854551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contraceptive discontinuation and pregnancy postabortion in Nepal: a longitudinal cohort study.
    Puri M; Henderson JT; Harper CC; Blum M; Joshi D; Rocca CH
    Contraception; 2015 Apr; 91(4):301-7. PubMed ID: 25553872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-acting contraceptive options.
    Kaunitz AM
    Int J Fertil Menopausal Stud; 1996; 41(2):69-76. PubMed ID: 8829701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of long-acting reversible contraception use among unmarried young adults.
    Dempsey AR; Billingsley CC; Savage AH; Korte JE
    Am J Obstet Gynecol; 2012 Jun; 206(6):526.e1-5. PubMed ID: 22425402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlates of use of long-acting reversible methods of contraception among adolescent and young adult women.
    Whitaker AK; Dude AM; Neustadt A; Gilliam ML
    Contraception; 2010 Apr; 81(4):299-303. PubMed ID: 20227545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teen pregnancy prevention on a LARC: an update on long-acting reversible contraception for the primary care provider.
    Dodson NA; Gray SH; Burke PJ
    Curr Opin Pediatr; 2012 Aug; 24(4):439-45. PubMed ID: 22732635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of trust in health care systems on postabortion contraceptive choice.
    Stacey RE; Dempsey A
    Contraception; 2015 Nov; 92(5):458-62. PubMed ID: 26197264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Awareness of long-acting reversible contraception among teens and young adults.
    Teal SB; Romer SE
    J Adolesc Health; 2013 Apr; 52(4 Suppl):S35-9. PubMed ID: 23535055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'But you can't reverse a hysterectomy!' Perceptions of long acting reversible contraception (LARC) among young women aged 16-24 years: a qualitative study.
    Okpo E; Allerton L; Brechin S
    Public Health; 2014 Oct; 128(10):934-9. PubMed ID: 25369357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-acting reversible contraception (LARC) use among adolescent females in secondary institutions in Nnewi, Nigeria.
    Eke AC; Alabi-Isama L
    J Obstet Gynaecol; 2011; 31(2):164-8. PubMed ID: 21281035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatricians' Attitudes and Beliefs about Long-Acting Reversible Contraceptives Influence Counseling.
    Berlan ED; Pritt NM; Norris AH
    J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):47-52. PubMed ID: 27639750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices.
    Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2012 Oct; 120(4):983-8. PubMed ID: 22996129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between Women's Use of Long-Acting Reversible Contraception and Declining Abortion Rates in New Zealand.
    Whitley CE; Rose SB; Sim D; Cook H
    J Womens Health (Larchmt); 2020 Jan; 29(1):21-28. PubMed ID: 31600111
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of a theory-based video on initiation of long-acting reversible contraception after abortion.
    Davidson AS; Whitaker AK; Martins SL; Hill B; Kuhn C; Hagbom-Ma C; Gilliam M
    Am J Obstet Gynecol; 2015 Mar; 212(3):310.e1-7. PubMed ID: 25265403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of users of intrauterine devices and other reversible contraceptive methods in the United States.
    Xu X; Macaluso M; Frost J; Anderson JE; Curtis K; Grosse SD
    Fertil Steril; 2011 Nov; 96(5):1138-44. PubMed ID: 21917255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.